Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Ratio
|
Ratios
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Per share ratios | |||||
| Adjusted EPS (Rs) | 32.43 | 21.00 | 26.10 | 53.13 | 31.96 |
| Adjusted cash EPS (Rs) | 36.77 | 28.43 | 33.19 | 61.46 | 39.99 |
| Reported EPS (Rs) | 33.35 | 21.00 | 24.83 | 53.13 | 31.96 |
| Reported cash EPS (Rs) | 37.70 | 28.43 | 31.91 | 61.46 | 39.99 |
| Dividend per share | 4.50 | 3.00 | 9.00 | 4.00 | 3.00 |
| Operating profit per share (Rs) | 37.96 | 29.54 | 25.15 | 70.31 | 45.84 |
| Book value (excl rev res) per share EPS (Rs) | 336.60 | 305.73 | 292.14 | 271.78 | 222.30 |
| Book value (incl rev res) per share EPS (Rs) | 336.60 | 305.73 | 292.14 | 271.78 | 222.30 |
| Net operating income per share EPS (Rs) | 181.69 | 218.32 | 192.63 | 270.06 | 226.41 |
| Free reserves per share EPS (Rs) | - | - | - | - | - |
| Profitability ratios | |||||
| Operating margin (%) | 20.89 | 13.53 | 13.05 | 26.03 | 20.24 |
| Gross profit margin (%) | 18.50 | 10.12 | 9.37 | 22.95 | 16.69 |
| Net profit margin (%) | 18.35 | 9.61 | 12.88 | 19.67 | 14.11 |
| Adjusted cash margin (%) | 19.13 | 12.59 | 16.26 | 21.93 | 17.14 |
| Adjusted return on net worth (%) | 9.63 | 6.86 | 8.93 | 19.54 | 14.37 |
| Reported return on net worth (%) | 9.90 | 6.86 | 8.49 | 19.54 | 14.37 |
| Return on long term funds (%) | 13.10 | 9.65 | 10.10 | 26.51 | 20.10 |
| Leverage ratios | |||||
| Long term debt / Equity | - | - | - | - | - |
| Total debt/equity | 0.14 | 0.23 | 0.10 | 0.24 | 0.28 |
| Owners fund as % of total source | 87.49 | 81.21 | 90.39 | 80.11 | 77.73 |
| Fixed assets turnover ratio | 0.47 | 0.62 | 0.58 | 0.86 | 0.81 |
| Liquidity ratios | |||||
| Current ratio | 3.52 | 4.44 | 4.20 | 3.92 | 4.29 |
| Current ratio (inc. st loans) | 1.12 | 1.15 | 1.78 | 1.16 | 1.16 |
| Quick ratio | 2.62 | 3.01 | 2.95 | 2.46 | 2.74 |
| Inventory turnover ratio | 0.47 | 0.57 | 0.59 | 0.79 | 0.79 |
| Payout ratios | |||||
| Dividend payout ratio (net profit) | 13.49 | 35.71 | 18.12 | 7.52 | 9.38 |
| Dividend payout ratio (cash profit) | 11.93 | 26.38 | 14.10 | 6.50 | 7.50 |
| Earning retention ratio | 86.13 | 64.29 | 82.77 | 92.48 | 90.62 |
| Cash earnings retention ratio | 87.77 | 73.62 | 86.45 | 93.50 | 92.50 |
| Coverage ratios | |||||
| Adjusted cash flow time total debt | 1.31 | 2.49 | 0.93 | 1.10 | 1.59 |
| Financial charges coverage ratio | 15.55 | 18.83 | 126.59 | 164.22 | 12.82 |
| Fin. charges cov.ratio (post tax) | 13.10 | 15.49 | 111.39 | 126.55 | 10.73 |
| Component ratios | |||||
| Material cost component (% earnings) | 56.67 | 58.44 | 52.58 | 46.90 | 52.17 |
| Selling cost Component | - | - | - | - | - |
| Exports as percent of total sales | 92.32 | 66.82 | 68.43 | 84.33 | 80.98 |
| Import comp. in raw mat. consumed | - | - | - | - | - |
| Long term assets / total Assets | 0.63 | 0.48 | 0.48 | 0.44 | 0.38 |
| Bonus component in equity capital (%) | 79.45 | 79.45 | 79.45 | 79.45 | 79.45 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis